Cargando…
A core epitope targeting antibody of SARS-CoV-2
Autores principales: | Zhao, Simeng, Liu, Fengjiang, Qiu, Shizhen, Lan, Qiaoshuai, Wu, Yiran, Xu, Wei, Ke, Junzi, Yang, Jie, Liu, Xiaoyan, Wang, Kun, Guo, Hangtian, Xia, Shuai, Zhang, Fangfang, Wang, Jiabei, Hu, Xiaowen, Lu, Lu, Jiang, Shibo, Zhao, Suwen, Liu, Lianxin, Xie, Youhua, Yang, Xiuna, Wang, Haopeng, Zhong, Guisheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871958/ https://www.ncbi.nlm.nih.gov/pubmed/36726762 http://dx.doi.org/10.1093/procel/pwac042 |
Ejemplares similares
-
A protective AAV vaccine for SARS-CoV-2
por: Zhao, Simeng, et al.
Publicado: (2022) -
Identification of natural products as novel ligands for the human 5-HT(2C) receptor
por: Peng, Yao, et al.
Publicado: (2018) -
Inefficiency of Sera from Mice Treated with Pseudotyped SARS-CoV to Neutralize 2019-nCoV Infection
por: Liu, Zezhong, et al.
Publicado: (2020) -
A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases
por: Zhou, Jie, et al.
Publicado: (2022) -
Spliced MDM2 isoforms promote mutant p53 accumulation and gain-of-function in tumorigenesis
por: Zheng, Tongsen, et al.
Publicado: (2013)